INTRODUCTION
Canine parvovirus (CPV) is a member of the autonomous parvoviruses and is associated with enteritis and myocarditis in dogs. Since the virus was discovered in 1978 (Appel et al., 1979; Burtonboy et al., 1979; Osterhaus et al., 1980; Gagnon and Povey, 1979) , inactivated or live attenuated vaccines have been used to prevent the disease. Owing to the presence of maternally derived antibodies, conventional vaccines may fail to induce protection in pups up to 16 weeks of age (Pollock and Carmichael, 1982) .
Recent developments in molecular biology and immunology may provide alternative vaccine strategies, based on the use of recombinant organisms, their products or synthetic peptides. A completely different approach, which might perhaps also overcome the interference by maternal antibodies, is the use of idiotypic structures for manipulation of the immune response towards immunity against CPV.
Since Jerne proposed his idiotypic network theory (Jerne, 1974) , much attention has been given to anti-idiotypic (anti-Id) antibodies as vaccin,; candidates against numerous infectious pathogens (Nisonoff and Lamoyi, i 981 ). The successful induction of a specific immune response to several viral antigens with anti-ld antibodies has been described (for review see Rimmeizwaan et al., 1989) .
Idiotypes (Id) are associated with the variable region of antibody molecules and are formed by the total set of determinants of the variable region, which are called idiotopes (Kunkel et al., 1963; Oudin and Michel, 1963) . Idiotypes have been defined by serological means, using anti-Id antibody preparations (Ab2) generated against the Id of the antibody reactive with the antigen (Abl). Different types of anti-Id antibodies can be distinguished (Jerne et al., 1982 ) . Ab2tx recognize idiotopes associated with the framework or the paratope of Ab 1. The binding of Ab2tx to Ab I may or may not be inhibited by antigen. If the binding of Ab2tx to Ab I is inhibitable by antigen, Ab2a are said to recognize paratope-related idiotopes. These kinds of Ab2c~ are sometimes referred to as Ab27. Ab2,8 are anti-Id antibodies which mitaic an antigenic determinant and bind like the epitope of an antigen to Ab I. The binding of Ab2,8 to Abl should be inhibitable by antigen and A2fl should recognize Id from several species induced by immunization with the same antigen (interspecies cross-reactive Id). Furthermore, Ab2fl must be able to induce an antibody response of the same specificity as the epitope that it mimics in different animal species or strains. Although Ab2 not displaying Ab2fl properties should not fully be excluded as candidates for immunization purposes (Francotte and Urbain, 1984; Schick et al., 1987; Zhou et al., 1987; Anders et al., 1989) , true Ab2fl should preferentially be considered for this purpose.
In this report we describe the generation and characterization of mouse monoclonal antibodies (MoAbs) recognizing Id CPV neutralizing MoAbs. These anti-ld antibodies did not fulfil all the criteria for Ab2fl and were classified as Ab2~,, reactive with private idiotopes (~diotopes uniquely associated with a given antibody molecule) of their respective Ab i. The potential use of these non-internal image anti-Id antibodies in immunization against CPV is discussed.
MATERIALS AND METHODS

Animals
BALB/c mice were raised in the animal facility of the National Institute of Public Health and Environmental Protection and were kept under specificpathogen-free (SPF) conditions.
Three 2-year-old SPF cats, free from all the known feline viruses, were kept under barrier-contained conditions. Two 3-year-old SPF dogs, free from all the known canine viruses, were kept under barrier-contained conditions. CPV antigen CPV antigen was purified by immunoaffinity chromatography (IAC) from culture supernatant as described previously (Rimmelzwaan et al., i 987 ) .
Monoclonal antibodies
The production, selection and characterization of MoAbs to CPV have been described previously (Rimmelzwaan et al., 1987) . Two of these virus neutralizing MoAbs, H-I (IgG2a x) and H-2 (IgG2b x), each recognizing a different epitope of the haemagglutinating protein of CPV were used to induce monoclonal Ab2. MoAbs H-I and H-2 were purified from ascitic fluid by affinity chromatography with protein-A sepharose essentially as indicated by the manufacturer (Pharmacia Fine Chemicals, Uppsala) and conjugated to keyhole limpet hemocyanin (KI__H) (Ca!biochem, La Jotda, CA) with g!utaraldehyde as previously described .
BALB/c mice were immunized subcutaneously by multipoint dose injections on Day 0 with 150/~g MoAb H-1 or H-2 conjugated to KLH in complete Freund's adjuvant (Difco Laboratories, Detroit) followed by subcutaneous multipoint dose booster injections of 150/zg in incomplete Freund's adjuvant at Day 14. After three intraperitoneal or intravenous injections with 100/zg purified MoAb H-I or MoAb H-2 on Days 28, 29 and 30, spleen cells were fused on Day 34 with mouse myeloma cells as described previously (Osterhaus et al., 1981 ) . Hybridomas were single cell cloned twice before their antiId MoAbs were used. Isotypes of MoAbs were determined in an ELISA system according to the prescriptions of the manufacturer (Zymed Laboratories Inc., San Francisco, CA).
F(ab')2 or Fab fragments of MoAbs H-1 and H-2
F (ab')2 fragments were prepared from protein-A sepharose purified MoAb H-l or control MoAb (IgG2a) by pepsin digestion. Purified IgG was dialyzed against saline for 16 h at 4 ° C. The solution was adjusted to pH 3.8 with 0.1 N HCI. One hundred units of pepsin (Cappel, Cooper Biomedical, Malvern) were added per milligram of IgG. After incubation at 37°C for 24 h the solution was adjusted to pH 8.0 with 0.1 N NaOH and was dialyzed against phosphate buffer pH 8.1 for 16 h at 4 ° C. F (ab') 2 fragments were isolated by chromatography on protein-A sepharose. The purity of the F (ab')2 fragments thus obtained was monitored by ELISA. Fifty microliter volumes of serial dilutions in carbonate buffer pH 9.6 of F(ab)2 fragments and starting material were coated for 2 h at 37°C onto microtiter plates (Titertek, Flow Laboratories). The plates were washed with demineralized water containing 0.05% Tween 80 and blocked with PBS containing 1% bovine serum albumin (BSA) (Organon Teknika, Oss, Netherlands). The extent of degradation was determined using horseradish peroxidase (HRP)-conjugated sheep anti-mouse IgG and goat anti-mouse IgG (gamma chain-specific) (Cappel, Cooper Biomedical, Malvern, U.S.A.). After incubation for 1 h at 37°C, the plates were washed and 0.1 ml volumes of substrate solution (0.1 mg/ml tetramethylbenzidine (TMB) (Sigma, St. Louis) ) and 0.003% H202 in 0.1 M NaAc buffer pH 5.5 were added to each well. The reaction was stopped after 10 min by adding 0.1 ml 2 M H2SO4. The absorbence was read in a Titertek Multiscan (Flow Laboratories).
Fab fragments were prepared from purified MoAb H-2 (IgG2b) by papain digestion. Ten to twenty micrograms of papain (Worthington, Flow Laboratories) were activated during 30 min at 37°C in 0.1 M phosphate buffer pH 7.8 containing 2 mM EDTA and 10 mM cysteine and were added to the IgG solution ( 1 mg/ml). After 4 h, the digestion was stopped by adding sodium acetamid at a final concentration of 10 mM (20 min at 37°C). The solutica was dialyzed and monovalent Fab were separated from Fc fragments and undegraded IgG by chromatography on protein-A sepharose. The extent of papain digestion was monitored by ELISA as described above.
Indirect ELISA for the detection of anti-Id (Ab2) antibodies
Microtiter plates were coated with F (ab')2 or Fab fragment preparations • of protein-A-purified MoAbs H-1 and H-2 and of control MoAbs by incubating 50/~1 volumes for 16 h at 4 ° C at a concentration of 4-6/~g/ml in carbonate buffer pH 9.6. After blocking with PBS containing 0.05% Tween 80 and 1% BSA, 50/zl volumes of hybridoma culture supernatants containing anti-Id antibodies were added to each well. Binding of Ab2 to Ab I was detected by adding 50 gl of HRP-conjugated goat anti-mouse IgG Fc (Cappel, Cooper Biomedical, Malvern, U.S.A.) to each well. After each incubation, the plates were washed with demineralized water containing 0.05% Tween 80. The plates were developed with TMB substrate as described above.
Idiotope cross-linking ELISA for the detection of anti-ld arltibodies (Ab2) or anti-anti-ld antibodies (Ab3)
Protein-A-purified H-I (IgG2a), H-2 (IgG2b) and control mouse MoAbs of the same isotype were bound onto micro ELISA plates (Titertek type III, Flow Laboratories) by incubating 50/zl volumes per well at a concentration of 4-6/~g/ml in 0.1 M carbonate buffer pH 9.6 at 20°C. After blocking the plates with PBS containing 0.06% Tween 80 and 1% BSA 50 #l ofhybridoma culture supernatant fluids containing anti-Ab I antibody were transferred to Abl-coated plates. After l h at 37°C, binding of Ab2 to Abl was detected by the detection of 50/~l of HRP-conjugated protein-A-purified Ab I. Plates were developed as described above using TMB as a substrate. After l0 min the reaction was stopped with 2 M H2SO4. The absorbence was read at 450 nm (A450) by using a Titertek Multiscan automatic plate reader (Flow Laboratories). Essentially the same technique was used for the demonstration of Ab3, using plate bound and HRP-conjugated purified monoclonal Ab2.
Inhibition ELISA for the detection of paratope-related idiotopes
Inhibition of the binding of anti-Id antibodies to F(ab' )2 and Fab fragments of their homologous plate-bound Ab I by CPV was considered to be indicative for specificity for antigen binding site-related idiotopes of Ab 1. Twofold serial dilutions of IAC-CPV were transferred to Plates coated with F(ab)2 fragments of MoAb H-1 or H-2, respectively. Controls were performed by incubation with diluent (PBS, containing 0.05% and 1% BSA), without viral antigen. After incubation for 1 h at 37°C, 50/~1 volumes ofhybridoma culture supernatant containing anti-Id antibodies were added at a concentration of 75% of maximal level of binding when tested without inhibition. The remaining binding of Ab2 was detected by the addition of HRPconjugated goat IgG anti-meuse IgG gamma chain-specific (Cappel, Cooper Biomedical, Malvern, U.S.A.). The plates were washed after each incubation with demineralized water containing 0.05% Tween 80. The plates were further developed as described above. The percentage of inhibition was calculated according to the formula: A450 uninhibited-A450 inhibited Inhibition-× 100 A450 uninhibited
Inhibition ELISA for Id specificity
To determine the Id specificity of the anti-Id antibodies, inhibition studies were performed with HRP-conjugated protein-A sepharose-purified Ab2. Plates were coated with 50/~1 volumes of MoAb H-1 or H-2 (200-300 ng per well in 0.1 M carbonate buffer pH 9.6). Tenfold serial dilutions of Ab2 were allowed to bind to their plate-bound homologous Ab I for I h at 37 ° C. Plates were then incubated with SO/~1 volumes of HRP-conjugated Ab2 at a dilution giving 75% of maximum binding of Ab2. The plates were washed after each incubation and developed as described above. Inhibition percentages were also calculated as described above.
Inhibition ELISA for the detection of cross-reactive idiotopes
The ability of immunoglobulins from pre-immune and immune sera of outbred SPF cats (n= 3 ), dogs (n=2) and BALB/c mice (pool of 10 mice) immunized with FPV or CPV and of MoAbs to CPV, to react with Ab2 was tested. The anti-CPV titers of the immune sera ranged from 300 to 2000 in haemagglutination inhibition tests. The titer of ascitic fluids of the anti-CPV MoAbs ranged from 104 to 5 X 104. Inhibition of the binding of Ab2 to Ab 1 by hyperimmune sera was supposed to be indicative for the recognition of interspecies cross-reactive idiotopes. Thirty microliters of Ab2 culture supernatants giving 75% of maximum binding in the indirect ELISA on F (ab')2 or Fab fragments were incubated with equal volumes of dilutions of the respective inhibitors for 16 h at 4 °C. The remaining anti-Ab I reactivity was assayed in the indirect ELISA on F(ab' )2 or Fab fragments as described above. Inhibition percentages were also calculated as described above.
RESULTS
Generation and selection of Id-specific MoAbs
The Id specificity of anti-Id MoAbs generated was assayed in the indirect ELISA or the Ids cross-linking ELISA using plate-bound Abl or isotype matched MoAbs as controls. From seven fusion events, a total of 33 hybridomas could be isolated, that produced antibodies reactive with the !d of CPV neutralizing MoAb H-I (31 of 33 ) or the Id of CPV neutralizing MoAb H-2 (2 of 33), but not with control Id, in the indirect ELISA and in most eases also in the cross-linking ELISA. The two anti-Id MoAbs directed to anti-CPV MoAb H-2 and five of the anti-Id MoAbs directed to anti-CPV MoAb H-1, which were arbitrarily chosen from a panel of I 1 anti-Id MoAbs that showed positive reactivity in both ELISAs and of which the binding to ld-coated plates could be inhibited by IAC-CPV, were selected for further study. This is because inhibition by antigen is considered to be one of the criteria for defining an anti-Id antibody as an internal image of an antigenic determinant. The Id specificities of these MoAbs are shown in Table 1 . Culture supernatants of Ab2 secreting hybridomas showed binding to the respective Ab I used for immunization but not to isotype matched mouse MoAb. The specificities of these anti-Id MoAbs for the respective Ab I were further confirmed in the inhibition ELISA. All MoAbs directed to anti-CPV MoAb H-1 failed to inhibit the binding of anti-Id MoAb 2-2-9 to anti-CPV MoAb H-2 and MoAbs to anti-CPV MoAb H-2 also failed to inhibit the binding of anti-Id MoAb 6-14-18 directed to MoAb H-1 (Table 2 ) . In order to classify the anti-Id MoAbs as either Ab2ct, Ab2fl or Ab2~, inhibition experiments with IAC-CPV antigen were performed. Therefore we examined whether the binding of Ab2 to Ab I could be inhibited by different amounts of CPV. As shown in Table 3 tigen ( < 10% inhibition; not shown) and should therefore be considered to be non-internal image Ab2a, the other 14 could be inhibited in this assay ( > 20% inhibition). This confirmed the specificity of the observed inhibition by IAC-CPV in the seven selected anti-ld MoAbs.
Determination of interspecies cross reactivities of selected anti-Id MoAbs
In order to determine whether the seven selected anti-Id MoAbs displayed true internal image Ab2fl activity, we examined the ability of dog (n = 2 ), cat (n= 3) and mouse anti-CPV serum antibodies to inhibit the Id-anti-Id reaction between the anti-CPV MoAb (Ab I ) and the respective anti-Id MoAbs (Ab2). As shown in Table 4 , the homologous Ab 1, used in the process of generating the respective anti-Id MoAbs, inhibited these reactivities almost completely (63-100%). None of the polyclonal antibody preparations, including the BALB/c mouse anti-CPV pooled serum, resulted in an inhibition in this assay. Thus the anti-Id MoAbs recognized idiotopes, which were not expressed in the normal response of the respective species to CPV, including BALB/c mice. Therefore it was concluded that they all define private, combining site related idiotopes on the respective Ab I (Ab27) and are non internal image Ab2fl.
Immunization of BALB/c mice with Ab2
To investigate whether antiviral antibodies could be induced with Ab27 in this system, three BALB/c mice were immunized with one of the following arbitrarily chosen Ab2: 2-23-9, 6-23-15 or 6-16-9. The immunization proto- 
HRP-conjugated anti-Id MoAbs
!~7-4 2-23-9 5-3-I 6°!4-!8 6-23-15 2-2-9 6-16-9
Inhibitor Cat 1 pre-serum < 5 ~ < 5 < 5 < 5 < 5 < 5 < 5
2 pre-serum < 5 < 5 < 5 < 5 < 5 < 5 < 5 3 pre-serum < 5 < 5 < 5 < 5 < 5 < 5 < 5
Cat 1 anti-FPV serum < 5 < 5 < 5 < 5 < 5 < 5 < 5 2 anti-FPV serum < 5 < 5 < 5 < 5 < 5 < 5 < 5 3 anti-FPV serum < 5 < 5 < 5 < 5 < 5 < 5 < 5
Dog 8 pre-serum
Dog 3 anti-CPV serum < 5 < 5 < 5 < 5 < 5 < 5 < 5 8 anti-CPV serum < 5 < 5 < 5 < 5 < 5 < 5 < 5
BALB/c mouse pre-serum (Francotte and Urbain, 1984) , hepatitis B virus (Schick et al., 1987 ) and influenza virus (Anders et al., 1989) .
This report describes the generation and characterization of monoclonal anti-Id antibodies directed to CPV neutralizing mouse MoAbs. However, these monoclonal anti-Id antibodies did not display all the characteristics of the true internal image Ab2fl mentioned. Although they did not recognize combining site related idiotopes (Table 3 ) , these idiotopes were not expressed in the antibody response of different animal species to CPV (Table 4 ) and should therefore be considered to be private idiotopes. Since also Ab2c~ and Ab2), anti-!d antibodies have been used for the induction of antiviral antibodies, we did consider the possibility of using the anti-id MoAbs generated in the CPV system for immunization purposes. If indeed it would be feasible to induce an anti-CPV response in puppies with anti-Id antibodies defining private idiotopes, this would offer the opportunity to overcome the interference by maternally derived anti-CPV antibodies experienced in vaccination with conventional vaccines (Pollock and Carmichael, 1982) . In contrast to conventional antigen or internal image Ab2p, anti-Id antibodies recognizing private idiotopes, not normally used in the repertoire of the species in response to CPV antigen, would not be recognized by maternal antibody. In this respect it is also interesting to realize that it has been shown that administration ofanti-Id antibodies in neonatal mice may lead to enhanced protection against infection with Escherichia coli (Stein and S/Sderstr/Sm, 1984) and that idiotypic manipulation by injecting lactating mice with Id or the suckling mouse neonates with anti-Id antibodies may lead to an enhanced immune response to the F glycoprotein of respiratory syncytial virus (Okamoto et al., 1989) . Our attempts to induce a specific CPV antibody response in BALB/c mice with these antMd monoclonal antibodies using immunization protocois which have been used in the systems described above have not been successful. Possibly other protocols, for example using sequential immunization with antiId antibodies defining private idiotopes Sanchez and Legrain, 1985 ) or aiming at the presentation of idiotypic structures by dendritic cells (Francotte and Urbain, 1985 ) , which lead to the induction of antigen-specific antibodies bearing private idiotopes, may prove to be successful in the CPV system.
